TITLE

Ezetimibe/Simvastatin vs Atorvastatin in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia: The VYTAL Study

AUTHOR(S)
Goldberg, Ronald B.; Guyton, John R.; Mazzone, Theodore; Weinstock, Ruth S.; Polis, Adam; Edwards, Patricia; Tomassini, Joanne E.; Tershakovec, Andrew M.
PUB. DATE
December 2006
SOURCE
Mayo Clinic Proceedings;Dec2006, Vol. 81 Issue 12, p1579
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: To compare the efficacy and safety of the recommended usual starting and next highest doses of ezetimibe/simvastatin and atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia. PATIENTS AND METHODS: This double-blind, multicenter study (June 22 to December 7, 2005) consisted of adult patients randomized to the recommended usual starting (ezetimibe/simvastatin, 10/20 mg/d, vs atorvastatin, 10 or 20 mg/d) or next highest (ezetimibe/simvastatin, 10/40 mg/d, vs atorvastatin, 40 mg/d) doses. Efficacy end points included percent changes from baseline in low-density lipoprotein cholesterol (LDL-C) levels (primary) and proportion of patients attaining LDL-C levels less than 70 mg/dL (secondary). RESULTS: A total of 1229 patients participated in the study. Significantly greater mean reductions were found in LDL-C levels with ezetimibe/simvastatin, 10/20 mg/d (-53.6%; 95% confidence interval [CI], -55.4% to -51.8%), than with atorvastatin, 10 mg/d (-38.3%; 95% CI, -40.1% to -36.5%; P<.001) or 20 mg/d (-44.6%; 95% CI. -46.4% to -42.8%; P<.001), and with ezettmibe/simvastatin, 10/40 mg/d (-57.6%; 95% CI, -59.4% to -55.8%). vs atorvastatin, 40 mg/d (-50.9%; 95% CI, -52.7% to -49.1%; P<.001). Ezetimibe/simvastatin was also superior to atorvastatin in attainment of LDL-C levels less than 70 mg/dL (P<.001 for all dose comparisons). Significantly better improvements with ezetimibe/simvastatin than with atorvastatin (P≤.001) were observed for total cholesterol, high-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol. Ezetimibe/simvastatin, 10/20 mg/d, reduced high-sensitivity C-reactive protein and triglyceride levels significantly more than atorvastatin, 10 mg/d (P=.O2), with comparable reductions at other doses. Incidences of clinical adverse events, including serious drug-related and prespecified gastrointestinal-, gallbladder-, and hepatitis-related allergic reactions or rash events, and laboratory adverse events, including repeated elevation of hepatic transaminases or creatine kinase levels, were similar for both treatments. CONCLUSION: Ezetimibe/simvastatin provided additional lipid-modifying benefits over atorvastatin monotherapy at the recommended usual starting and next highest doses in patients with type 2 diabetes. Both treatments were generally well tolerated.
ACCESSION #
24100728

 

Related Articles

  • Does the LDL Receptor Play a Role in the Risk of Developing Type 2 Diabetes? Preiss, David; Sattar, Naveed // JAMA: Journal of the American Medical Association;3/10/2015, Vol. 313 Issue 10, p1016 

    The authors reflect on the role of low-density lipoprotein (LDL) receptor in the risk of developing type 2 diabetes. Topics discussed include how statins can contribute to the development of type 2 diabetes, genetic testing for familial hypercholesterolemia and a study on the prevalence of...

  • Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus. Besseling, Joost; Kastelein, John J. P.; Defesche, Joep C.; Hutten, Barbara A.; Hovingh, G. Kees // JAMA: Journal of the American Medical Association;3/10/2015, Vol. 313 Issue 10, p1029 

    IMPORTANCE. Familial hypercholesterolemia is characterized by impaired uptake of cholesterol in peripheral tissues, including the liver and the pancreas. In contrast, statins increase the cellular cholesterol uptake and are associated with increased risk for type 2 diabetes mellitus. We...

  • Association of dietary fiber intake with serum total cholesterol and low density lipoprotein cholesterol levels in Urban Asian-Indian adults with type 2 diabetes. Narayan, Shreya; Lakshmipriya, Nagarajan; Vaidya, Ruchi; Bai, Mookambika Ramya; Sudha, Vasudevan; Krishnaswamy, Kamala; Unnikrishnan, Ranjit; Anjana, Ranjit Mohan; Mohan, Viswanathan // Indian Journal of Endocrinology & Metabolism;Sep/Oct2014, Vol. 18 Issue 5, p624 

    Context: There is little data correlating dietary fibre (DF) intake and cardiovascular risk in Asian Indians with diabetes. Aim: To assess the DF intake and its association with lipid profile (total serum cholesterol and low density lipoprotein [LDL] - cholesterol levels) in urban Asian Indians...

  • THE TEEN OBESITY CRISIS.  // Dolly;Sep2006, Issue 431, p52 

    The article focuses on teenage obesity crisis. Basically, obesity is caused by eating too much and not doing enough physical activity. Individuals may be at a higher risk of becoming overweight if they are emotional eaters, or have a genetic predisposition to putting on weight. The medical...

  • SCIENTIFIC UPDATE. Mangels, Reed // Vegetarian Journal;2005, Vol. 24 Issue 2, p12 

    Presents several scientific research related to vegetarianism. Observation of lower risk of gall bladder removal among women with a high intake of vegetable protein; Relation between an increase risk of type 2 diabetes and high intake of red and processed meat; Reduction in blood cholesterol...

  • Common Variation in LMNA Increases Susceptibility to Type 2 Diabetes and Associates With Elevated Fasting Glycemia and Estimates of Body Fat and Height in the General Population. Wegner, Lise; Andersen, Gitte; Sparsø, Thomas; Grarup, Niels; Glümer, Charlotte; Borch-Johnsen, Knut; Jørgensen, Torben; Hansen, Torben; Pedersen, Oluf // Diabetes;Mar2007, Vol. 56 Issue 3, p694 

    Mutations in LMNA encoding lamin A and C proteins cause monogenic syndromes characterized by muscular dystrophy and familial partial lipodystrophy. Eight tag single nucleotide polymorphisms in the LMNA locus were genotyped in 7,495 Danish whites and related to metabolic and anthropometric...

  • Association of Lower Serum Cholesterol Levels With Higher Risk of Osteoporosis in Type 2 Diabetes. Farsad Afshinnia; Shobha Chacko; Tooraj Zahedi // Endocrine Practice;Oct2007, Vol. 13 Issue 6, p620 

    Objective: To determine whether a correlation exists between bone mineral density and circulating lipoprotein levels and whether these variables are independently associated with osteoporosis in patients with type 2 diabetes.Methods: In a cross-sectional analysis, 159 patients with type 2...

  • The impact of war on Sarajevans with non-insulin-dependent diabetes mellitus. KULENOVIC, INDIRA; ROBERTSON, AILEEN; GRUJIC, MIRKO; SULJEVIC, ENVER; SMAJKIC, ARIF // European Journal of Public Health;1995, Vol. 6 Issue 4, p252 

    The objective of this study was to investigate the impact of almost 3 years of war on glycaemic control and blood pressure in Sarajevans with non-insulln-dependent diabetes mellitus (NIDDM). Fifty-five patients with NIDDM were randomly selected from a register of 279. Data from pre-war records...

  • STITCH IN TIME. Bjerklie, David // Time International (South Pacific Edition);10/25/2004, Issue 42, p85 

    The article cites a report which states that stomach stapling and gastric bypass surgery clearly help people shed extra fat, but the benefits go well beyond weight loss. A review of 130 studies involving 22,000 patients showed that for most there were also dramatic improvements with respect to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics